COMMUNIQUÉS West-GlobeNewswire

Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year

07/04/2025 - 13:00

FRIENDSWOOD, Texas, April 07, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received a Top [...]

Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

07/04/2025 - 12:58

Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelines Enrollment underway in CHAPTER-3, a pivotal [...]

Telix Appoints Paul Schaffer as Chief Technology Officer

07/04/2025 - 12:30

MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly [...]

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

07/04/2025 - 12:30

HUNTSVILLE, AL, April 07, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology [...]

Transactions under Novonesis’ share buyback program

07/04/2025 - 12:29

Please read the announcement in PDF Attachment 2025_17_Share_buyback_program

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

07/04/2025 - 12:00

Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants across cardiac [...]

European Commission approves Johnson & Johnson’s subcutaneous DARZALEX® (daratumumab)-based quadruplet regimen for the treatment of patients with newly diagnosed multiple myeloma, regardless of transplant eligibility

07/04/2025 - 11:32

Approval cements daratumumab as a foundational therapy in newly diagnosed multiple myeloma and the only anti-CD38 antibody for all patient types in this setting Phase 3 CEPHEUS study shows significant improvement in [...]

LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer

07/04/2025 - 08:00

Mark brings 30 years of experience in R&D spanning discovery to late-stage clinical development London, 7 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and world leader in [...]

Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director

07/04/2025 - 08:00

Accomplished biotech investor with a track record of successful company-building and exits to lead Angelini Ventures’ international BioTech investment strategy Rome, Italy, 7 April 2025 – Angelini Ventures, the [...]

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity

06/04/2025 - 18:00

Company to host conference call on April 7 at 8 a.m. ET BOSTON, April 06, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming [...]

Scarless MTF Breast Augmentation Performed by Seattle Plastic Surgeon

05/04/2025 - 17:30

Dr. Sajan Delivers Natural-Looking Transgender Breast Augmentation Without Chest Scars SEATTLE, April 05, 2025 (GLOBE NEWSWIRE) -- For transgender women, breast augmentation is a profoundly emotional step toward [...]

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

05/04/2025 - 17:30

ATTENTION-AD trial data through 192 weeks presented at AD/PD TM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine and importance of early and continued long-term [...]

Arialief Reviews (SHOCKING REPORT!) Is This Sciatic Nerve Relief Supplement Safe or Overhyped Hoax?

05/04/2025 - 09:59

HONOLULU, Hawaii, April 05, 2025 (GLOBE NEWSWIRE) -- Arialief is nutritional support specifically designed to offer sciatic nerve relief. It contains selected ingredients that work to alleviate the burning, tingling, [...]

PacBio Grants Equity Incentive Award to New Employee

05/04/2025 - 01:45

MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s [...]

AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal

04/04/2025 - 22:45

OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types [...]

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

04/04/2025 - 22:34

Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second [...]

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/04/2025 - 22:30

WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04/04/2025 - 22:30

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]

Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan

04/04/2025 - 22:17

A New Era in Autism Therapy BAODING, China, April 05, 2025 (GLOBE NEWSWIRE) -- European Wellness Biomedical Group (EWBG) , a global pioneer in bioregenerative medicine and wellness innovation, today unveiled new [...]